Passive antibody therapy in COVID-19 | Nature Reviews Immunology
Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside | Immunotherapy
Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | Full Text
Hunting for antibodies to combat COVID‑19
References in Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors - Experimental Hematology
Future perspectives of therapeutic monoclonal antibodies | Immunotherapy
JCM | Free Full-Text | Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma | HTML
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Frontiers | Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics | Oncology
IJMS | Free Full-Text | Monoclonal Antibodies for Chronic Pain Treatment: Present and Future | HTML
Immunosuppressive monoclonal antibodies: current and next generation - Clinical Microbiology and Infection
Neutralizing monoclonal antibodies for treatment of COVID-19 | Nature Reviews Immunology
Cancers | Free Full-Text | Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities | HTML
Mechanisms of action of monoclonal antibodies. MAbs may act through... | Download Scientific Diagram
Role of IgG Fc Receptors in Monoclonal Antibody Therapy of Cancer - ScienceDirect
Mechanism of action of therapeutic monoclonal antibodies: Promises and pitfalls of in vitro and in vivo assays - ScienceDirect
Monoclonal Antibody Therapy in Multiple Sclerosis - Practical Neurology
Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2: Trends in Pharmacological Sciences
What are monoclonal antibodies – and can they treat Covid-19? | News | Wellcome
Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside | Immunotherapy
Figure 1 | Monoclonal Antibodies for Non-Hodgkin's Lymphoma: State of the Art and Perspectives
Proof-of-concept experimental therapies of cancer and mechanisms of resistance to anti-cancer drugs | Yosef (Yossi) Yarden's Lab